322 related articles for article (PubMed ID: 1348623)
1. P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines.
Huet S; Schott B; Robert J
Br J Cancer; 1992 Apr; 65(4):538-44. PubMed ID: 1348623
[TBL] [Abstract][Full Text] [Related]
2. Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine.
Schott B; Bennis S; Pourquier P; Ries C; Londos-Gagliardi D; Robert J
Int J Cancer; 1993 Aug; 55(1):115-21. PubMed ID: 8102127
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and molecular characterization of intrinsic and acquired doxorubicin resistance in murine tumor cell lines.
Schott B; Londos-Gagliardi D; Ries C; Huet S; Robert J
J Cancer Res Clin Oncol; 1993; 119(9):527-32. PubMed ID: 8100823
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
[TBL] [Abstract][Full Text] [Related]
5. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
6. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J
Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865
[TBL] [Abstract][Full Text] [Related]
7. Differential stabilization of topoisomerase-II-DNA cleavable complexes by doxorubicin and etoposide in doxorubicin-resistant rat glioblastoma cells.
Montaudon D; Pourquier P; Denois F; de Tinguy-Moreaud E; Lagarde P; Robert J
Eur J Biochem; 1997 Apr; 245(2):307-15. PubMed ID: 9151958
[TBL] [Abstract][Full Text] [Related]
8. Dominant expression of multiple drug resistance after in vitro X-irradiation exposure in intraspecific Chinese hamster ovary hybrid cells.
McClean S; Hosking LK; Hill BT
J Natl Cancer Inst; 1993 Jan; 85(1):48-53. PubMed ID: 8093217
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture.
Bennis S; Chapey C; Couvreur P; Robert J
Eur J Cancer; 1994; 30A(1):89-93. PubMed ID: 8142172
[TBL] [Abstract][Full Text] [Related]
10. Azelastine and flezelastine as reversing agents of multidrug resistance: pharmacological and molecular studies.
Hu YP; Robert J
Biochem Pharmacol; 1995 Jul; 50(2):169-75. PubMed ID: 7632160
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of doxorubicin-resistant Lewis lung carcinoma variants.
Bruno NA; Carver LA; Slate DL
Cancer Commun; 1990; 2(4):151-8. PubMed ID: 1973357
[TBL] [Abstract][Full Text] [Related]
12. Cellular pharmacology of 4'-iodo-4'-deoxydoxorubicin.
Schott B; Vrignaud P; Ries C; Robert J; Londos-Gagliardi D
Br J Cancer; 1990 Apr; 61(4):543-7. PubMed ID: 2331441
[TBL] [Abstract][Full Text] [Related]
13. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
Lee FY; Sciandra J; Siemann DW
Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
15. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.
Taylor CW; Dalton WS; Parrish PR; Gleason MC; Bellamy WT; Thompson FH; Roe DJ; Trent JM
Br J Cancer; 1991 Jun; 63(6):923-9. PubMed ID: 1676902
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of multiple drug resistance in human bladder cancer cell lines.
Shinohara N; Liebert M; Wedemeyer G; Chang JH; Grossman HB
J Urol; 1993 Aug; 150(2 Pt 1):505-9. PubMed ID: 8100862
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin retention and chemoresistance in human mesothelioma cell lines.
Isobe H; Wellham L; Sauerteig A; Sridhar KS; Ramachandran C; Krishan A
Int J Cancer; 1994 May; 57(4):581-5. PubMed ID: 7910154
[TBL] [Abstract][Full Text] [Related]
19. Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants.
Pavillard V; Kherfellah D; Richard S; Robert J; Montaudon D
Br J Cancer; 2001 Sep; 85(7):1077-83. PubMed ID: 11592782
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
Nielsen D; Skovsgaard T
Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
